Multivariate determinants of the need for postoperative ventilation in myasthenia gravis

Canadian Journal of Anaesthesia

Volumn 43, Issue 10, 1996, Pages 1006-1013

  Naguib, Mohamed ^a,b   El Dawlatly, Abdel Azim ^a   Ashour, Mahmoud ^a   Bamgboye, Elijah A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

anaesthesia: outcome; complications: myasthenia gravis; neuromuscular transmission: myasthenia gravis; statistics: multivariate discriminant analysis, the receiver operating characteristic (ROC) curve; surgery: thymectomy; ventilation: postoperative, mechanical

Indexed keywords

AZATHIOPRINE; GLUCOCORTICOID; PYRIDOSTIGMINE;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; MULTIVARIATE ANALYSIS; MYASTHENIA GRAVIS; POSTOPERATIVE CARE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; THYMECTOMY; TREATMENT OUTCOME;

EID: 0029913579     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03011901     Document Type: Article

References (30)

1. Loach AB, Young AC, Spalding JMK, Crampton Smith A. Postoperative management after thymectomy. BMJ 1975; 1: 309-12.
2. Mintz S, Peterson SR, MacFarland D, Petajan J, Richards RC. The current role of thymectomy for myasthenia gravis. Am J Surg 1980; 140: 734-7.
3. Leventhal SR, Orkin FK, Hirsh RA. Prediction of the need of postoperative mechanical ventilation in myasthenia gravis. Anesthesiology 1980; 52: 26-30.
4. Orkin FK, Leventhal SR, Hirsh RA. Predicting respiratory failure following thymectomy. Ann NY Acad Sci 1981; 377: 862-3.
5. Grant RP, Jenkins LC. Prediction of the need for postoperative mechanical ventilation in myasthenia gravis: thymectomy compared to other surgical procedures. Can Anaesth Soc J 1982; 29: 112-6.
6. Gracey DR, Divertie MB, Howard FM Jr, Payne WS. Postoperative respiratory care after transsternal thymectomy in myasthenia gravis. A 3-year experience in 53 patients. Chest 1984; 86: 67-71.
7. Toyka KV. Myasthenia gravis. In: Johnson RT (Ed.). Current Therapy in Neurologic Disease. Philadelphia: BC Decker Inc., 1990: 385-91.
8. Chan KH, Yang MW, Huang MH, et al. A comparison between vecuronium and atracurium in myasthenia gravis. Acta Anaesthesiol Scand 1993, 37: 679-82.
9. Paterson IG, Hood JR, Russell SH, Weston MD, Hirsch NP. Mivacurium in the myasthenic patient. Br J Anaesth 1994; 73: 494-8.
10. Jaretzki A III, Wolff M. "Maximal" thymectomy for myasthenia gravis. Surgical anatomy and operative technique. J Thorac Cardiovasc Surg 1988; 96: 711-6.
11. Osserman KE, Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971; 38: 497-537.
12. Naguib M, Sari-Kouzel A, Ashour M, Seraj M, Messahel F. Myasthenia gravis and pipecuronium. Report of two cases. Middle East J Anaesthiol 1992; 11: 381-90.
13. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
14. Eisenkraft JB, Papatestas AE, Khan CH, Mora CT, Fagerstrom R, Genkins G. Predicting the need for postoperative mechanical ventilation in myasthenia gravis. Anesthesiology 1986; 65: 79-82.
15. Gal TJ. Pulmonary function testing. In: Miller RD (Ed.). Anesthesia, 4th ed. New York: Churchill Livingstone, 1994: 883-901.
16. Younger DS, Braun NMT, Jaretzki A III, Penn AS, Lovelace RE. Myasthenia gravis: determinants for independent ventilation after transsternal thymectomy. Neurology 1984; 34: 336-40.
17. Ringqvist I, Ringqvist T. Respiratory mechanics in untreated myasthenia gravis with special reference to the respiratory forces. Acta Med Scand 1971; 190: 499-508.
18. Suratt PM, Hooe DM, Owens DA, Anne A. Effect of maximal versus submaximal expiratory effort on spirometric values. Respiration 1981; 42: 233-6.
19. Eisenkraft JB. Myasthenia gravis and thymic surgery - anaesthetic considerations. Bailliere's Clinical Anesthesiology 1987; 1: 133-62.
20. Oosterhuis HJGH. Clinical aspects. In: Myasthenia Gravis. Edinburgh: Churchill Livingstone, 1984: 21-50.
21. Carbone A, Piantelli M, Musiani P, et al. Estrogen binding sites in peripheral blood mononuclear cells and thymocytes from 2 myasthenia gravis patients. J Clin Lab Immunol 1986; 21: 87-91.
22. Andrews PI, Massey JM, Howard JF Jr, Sanders DB. Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis. Neurology 1994; 44: 1208-14.
23. Frambrough DM, Drachman DB, Satyamurti S. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science 1973; 182: 293-5.
24. Drachman DB, Angus CW, Adams RN, Michelson JD, Hoffman GJ. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med 1978; 198: 1116-22.
25. Burges J, Wray DW, Pizzighella S, Hall Z, Vincent A. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro. Muscle Nerve 1990; 13: 407-13.
26. Baraka A, Wakid N, Mansour R, Haddad W. Effect of neostigmine and pyridostigmine on the plasma cholinesterase activity. Br J Anaesth 1981; 53: 849-51.
27. Lumley J. Prolongation of suxamethonium following plasma exchange. Br J Anaesth 1980; 52: 1149-50.
28. Nilsson E, Paloheimo M, Mütter K, Heinonen J. Halothane-induced variability in the neuromuscular transmission of patients with myasthenia gravis. Acta Anaesthesiol Scand 1989; 33: 395-401.
29. Rowbottom SJ. Isoflurane for thymectomy in myasthenia gravis. Anaesth Intensive Care 1989; 17: 444-7.
30. Nilsson E, Muller K. Neuromuscular effects of isoflurane in patients with myasthenia gravis. Acta Anaesthesiol Scand 1990; 34: 126-31.